About biovie inc - BIVI
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
BIVI At a Glance
BioVie, Inc.
680 West Nye Lane
Carson City, Nevada 89703
| Phone | 1-775-888-3162 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -22,072,863.00 | |
| Sector | Health Technology | Employees | 13 | |
| Fiscal Year-end | 06 / 2027 | |||
| View SEC Filings |
BIVI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 1.425 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.238 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.051 |
BIVI Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,697,912.538 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
BIVI Liquidity
| Current Ratio | 3.594 |
| Quick Ratio | 3.594 |
| Cash Ratio | 2.365 |
BIVI Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -123.268 |
| Return on Equity | -150.759 |
| Return on Total Capital | -209.307 |
| Return on Invested Capital | -148.428 |
BIVI Capital Structure
| Total Debt to Total Equity | 2.682 |
| Total Debt to Total Capital | 2.612 |
| Total Debt to Total Assets | 1.933 |
| Long-Term Debt to Equity | 1.796 |
| Long-Term Debt to Total Capital | 1.749 |